Daijiworld Media Network - New Delhi
New Delhi, Nov 19: The National Pharmaceutical Pricing Authority (NPPA) has extended the validity of existing ceiling prices for orthopaedic knee implants used in knee replacement surgeries by two months, until January 15, 2027.
According to a notification published in the Press Gazette, the extension comes as the authority examines representations received from manufacturers and industry associations.

The existing price controls were last extended on November 14, 2025, and were scheduled to remain in force until November 15, 2026. The latest extension comes amid growing demands for rationalisation of trade margins on medical devices.
Rajiv Nath, Forum Coordinator of the Association of Indian Medical Device Industry (AiMeD), welcomed the decision, saying the extension would allow stakeholder representations to be examined.
He said India had developed strong domestic manufacturing capabilities and that advanced technologies were already available within the existing pricing framework.
Nath added that any future revision of the price caps should be based on an objective assessment of market data, patient affordability and the need to strengthen domestic manufacturing under the Make in India and Atmanirbhar Bharat initiatives.